Navigation Links
Frontier® II CRT-P

ProductsFrontier® II CRT-P
Company St. Jude Medical, Inc.
Item Frontier® II CRT-P
Features 
  • Biventricular pacing capabilities
  • Advanced AT/AF diagnostics
  • Atrial arrhythmia detection rate
  • Stored electrograms
Description The Frontier II device is designed to reduce the symptoms of moderate to severe heart failure (NYHA Class III or IV) in patients who are symptomatic despite stable, optimal medical therapy and who have prolonged QRS duration and left-ventricular EF < 35%.
Info St. Jude Medical, Inc.
Customer Service: (800) 328-9634
Web site: http://www.sjm.com

Related medicine products :

1. Frontier® CRT-P Biventricular Stimulation Device
2. Frontier CRT-P
Breaking Medicine Technology:Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 3Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 2Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 3NetMotion Wireless Boosts Mobile Productivity for Bell Ambulance 53877 1NetMotion Wireless Boosts Mobile Productivity for Bell Ambulance 53877 2NetMotion Wireless Boosts Mobile Productivity for Bell Ambulance 53877 3Cooperation Between Faith Based Organizations and UNFPA Critical to Maternal Health Say Groups 53875 1Cooperation Between Faith Based Organizations and UNFPA Critical to Maternal Health Say Groups 53875 2President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 1President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 2President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 3President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 4